KORU Medical Systems, Inc. ( KRMD ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Linda Tharby - President, CEO & Director Tom Adams - CFO, Secretary & Treasurer Conference Call Participants Louisa Smith - Gilmartin Group LLC Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Caitlin Cronin - Canaccord Genuity Corp., Research Division Joseph Downing - Piper Sandler & Co., Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Greetings, and welcome to KORU Medical Systems Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded.
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago.
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Linda M. Tharby - President, CEO & Director Thomas Adams - CFO, Secretary & Treasurer Conference Call Participants Anderson Schock - B.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Linda M. Tharby CEO | NASDAQ (CM) Exchange | 759910102 CUSIP |
| US Country | 80 Employees | - Last Dividend | - Last Split | 20 Mar 1996 IPO Date |
KORU Medical Systems, Inc. is a pioneering firm that specializes in the development and manufacturing of essential medical devices and supplies, with its influence extending both within the United States and internationally. Founded in 1980 and headquartered in Mahwah, New Jersey, the company has cemented its position as a critical provider in the healthcare sector. KORU's primary mission revolves around enhancing the lives of patients battling chronic illnesses through the provision of innovative infusion systems, particularly targeting individuals suffering from primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. These contributions significantly improve the quality of life for their users, allowing for life-saving therapies to be more accessible, efficient, and comfortable.
KORU Medical Systems offers a diverse range of products designed to meet the needs of patients requiring infusion therapies. These offerings include: